Published in World J Orthop on November 18, 2012
Insulin resistance and bone strength: findings from the study of midlife in the United States. J Bone Miner Res (2014) 0.82
Interaction between bone and muscle in older persons with mobility limitations. Curr Pharm Des (2014) 0.77
Low and Normal IGF-1 Levels in Patients with Chronic Medical Disorders (CMD) is Independent of Anterior Pituitary Hormone Deficiencies: Implications for Treating IGF-1 Abnormal Deficiencies with CMD. J Genet Syndr Gene Ther (2013) 0.75
Positional cloning of the mouse obese gene and its human homologue. Nature (1994) 38.85
Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med (2001) 16.81
High bone density due to a mutation in LDL-receptor-related protein 5. N Engl J Med (2002) 11.28
Endocrine regulation of energy metabolism by the skeleton. Cell (2007) 10.41
Identification and expression cloning of a leptin receptor, OB-R. Cell (1995) 9.74
Wnt/beta-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis. Dev Cell (2005) 8.16
Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell (2000) 7.87
Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation. Dev Cell (2005) 7.64
Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature (1998) 7.36
Leptin receptor signaling in POMC neurons is required for normal body weight homeostasis. Neuron (2004) 7.15
Biological action of leptin as an angiogenic factor. Science (1998) 6.02
Leptin regulates bone formation via the sympathetic nervous system. Cell (2002) 5.95
Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum. Cell (2008) 5.93
Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. J Clin Invest (2002) 5.83
Regulation of bone mass by Wnt signaling. J Clin Invest (2006) 5.59
Increased bone formation in osteocalcin-deficient mice. Nature (1996) 4.91
Effect of selective serotonin reuptake inhibitors on the risk of fracture. Arch Intern Med (2007) 4.68
Phenotypes of mouse diabetes and rat fatty due to mutations in the OB (leptin) receptor. Science (1996) 4.59
The serotonin signaling system: from basic understanding to drug development for functional GI disorders. Gastroenterology (2007) 4.58
Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARgamma. Science (1996) 4.50
Osteocalcin and matrix Gla protein: vitamin K-dependent proteins in bone. Physiol Rev (1989) 3.87
Selective deletion of leptin receptor in neurons leads to obesity. J Clin Invest (2001) 3.82
Decreased cerebrospinal-fluid/serum leptin ratio in obesity: a possible mechanism for leptin resistance. Lancet (1996) 3.79
The leptin receptor. J Biol Chem (1997) 3.76
Nonadipose tissue production of leptin: leptin as a novel placenta-derived hormone in humans. Nat Med (1997) 3.35
A serotonin-dependent mechanism explains the leptin regulation of bone mass, appetite, and energy expenditure. Cell (2009) 3.28
Leptin receptor-mediated signaling regulates hepatic fibrogenesis and remodeling of extracellular matrix in the rat. Gastroenterology (2002) 2.97
Association between serum osteocalcin and markers of metabolic phenotype. J Clin Endocrinol Metab (2008) 2.84
Effect of recombinant human parathyroid hormone (1-84) on vertebral fracture and bone mineral density in postmenopausal women with osteoporosis: a randomized trial. Ann Intern Med (2007) 2.64
Anatomic localization of alternatively spliced leptin receptors (Ob-R) in mouse brain and other tissues. Proc Natl Acad Sci U S A (1997) 2.57
Leptin secretion and leptin receptor in the human stomach. Gut (2000) 2.46
Serum undercarboxylated osteocalcin was inversely associated with plasma glucose level and fat mass in type 2 diabetes mellitus. Osteoporos Int (2010) 2.40
Bone recognition mechanism of porcine osteocalcin from crystal structure. Nature (2003) 2.35
Leptin is expressed in and secreted from primary cultures of human osteoblasts and promotes bone mineralization. J Bone Miner Res (2001) 2.15
Leptin directly regulates bone cell function in vitro and reduces bone fragility in vivo. J Endocrinol (2002) 1.93
Osteocalcin. Biochemical considerations and clinical applications. Clin Orthop Relat Res (1988) 1.93
Collagen cross-linking in human bone and articular cartilage. Age-related changes in the content of mature hydroxypyridinium residues. Biochem J (1988) 1.79
Bone as an endocrine organ. Trends Endocrinol Metab (2009) 1.75
Erk is essential for growth, differentiation, integrin expression, and cell function in human osteoblastic cells. J Biol Chem (2001) 1.74
The vitamin K-dependent carboxylase. Annu Rev Nutr (2005) 1.72
The pancreatic beta cell is a key site for mediating the effects of leptin on glucose homeostasis. Cell Metab (2006) 1.70
The osteoblast: an insulin target cell controlling glucose homeostasis. J Bone Miner Res (2011) 1.70
Use of beta-blockers and risk of fractures. JAMA (2004) 1.58
Beta-adrenergic blockers reduce the risk of fracture partly by increasing bone mineral density: Geelong Osteoporosis Study. J Bone Miner Res (2004) 1.50
Leptin stimulates human osteoblastic cell proliferation, de novo collagen synthesis, and mineralization: Impact on differentiation markers, apoptosis, and osteoclastic signaling. J Cell Biochem (2002) 1.49
Leptin receptor signaling and the regulation of mammalian physiology. Int J Obes (Lond) (2008) 1.48
Leptin reduces ovariectomy-induced bone loss in rats. Endocrinology (2001) 1.40
Evolution of leptin structure and function. Neuroendocrinology (2011) 1.34
Dissociation of the neuronal regulation of bone mass and energy metabolism by leptin in vivo. Proc Natl Acad Sci U S A (2008) 1.34
Fat and bone in children: differential effects of obesity on bone size and mass according to fracture history. J Bone Miner Res (2010) 1.33
Plasma leptin concentrations are associated with bone mineral density and the presence of vertebral fractures in postmenopausal women. Clin Endocrinol (Oxf) (2001) 1.30
Obesity is associated with a decreased leptin transport across the blood-brain barrier in rats. Diabetes (2000) 1.26
beta-Blocker use, BMD, and fractures in the study of osteoporotic fractures. J Bone Miner Res (2004) 1.25
Leptin acts as a growth factor on the chondrocytes of skeletal growth centers. J Bone Miner Res (2002) 1.16
Amylin inhibits bone resorption while the calcitonin receptor controls bone formation in vivo. J Cell Biol (2004) 1.12
Evolution of Class I cytokine receptors. BMC Evol Biol (2007) 1.12
The complex effects of leptin on bone metabolism through multiple pathways. Curr Opin Pharmacol (2004) 1.12
Genetic mouse models for bone studies--strengths and limitations. Bone (2011) 1.10
Low density lipoprotein receptor-related protein 5 (LRP5) mutations and osteoporosis, impaired glucose metabolism and hypercholesterolaemia. Clin Endocrinol (Oxf) (2009) 1.10
Leptin, body composition and bone mineral density in premenopausal women. Calcif Tissue Int (2003) 1.10
Comparison of biochemical indexes for assessing vitamin K nutritional status in a healthy adult population. Am J Clin Nutr (1996) 1.08
Potential role of leptin in endochondral ossification. J Histochem Cytochem (2002) 1.07
The two faces of serotonin in bone biology. J Cell Biol (2010) 1.05
Change in undercarboxylated osteocalcin is associated with changes in body weight, fat mass, and adiponectin: parathyroid hormone (1-84) or alendronate therapy in postmenopausal women with osteoporosis (the PaTH study). J Clin Endocrinol Metab (2011) 1.03
Detection and quantification of the leptin receptor splice variants Ob-Ra, b, and, e in different mouse tissues. Biochem Biophys Res Commun (1997) 1.03
Coincident diabetes mellitus and primary hyperparathyroidism. Diabetes Metab Res Rev (2001) 1.02
Effects of calcitonin, amylin, and calcitonin gene-related peptide on osteoclast development. Bone (2001) 0.98
Leptin induces growth hormone secretion from peripheral blood mononuclear cells via a protein kinase C- and nitric oxide-dependent mechanism. Endocrinology (2003) 0.98
Beta-blockers increase bone mineral density. Clin Orthop Relat Res (2006) 0.96
Leptin receptor isoform expression in rat osteoblasts and their functional analysis. FEBS Lett (2002) 0.95
Overexpression of the Wilms' tumor gene WT1 in human bone and soft-tissue sarcomas. Cancer Sci (2003) 0.94
Role of central leptin signaling in the starvation-induced alteration of B-cell development. J Neurosci (2011) 0.94
Effects of beta-adrenergic agonists on bone-resorbing activity in human osteoclast-like cells. Biochim Biophys Acta (2003) 0.91
Molecular evolution of leptin. Gen Comp Endocrinol (2001) 0.90
Systemic administration of amylin increases bone mass, linear growth, and adiposity in adult male mice. Am J Physiol (1998) 0.90
Leptin-dependent co-regulation of bone and energy metabolism. Aging (Albany NY) (2009) 0.89
Peripheral insulin resistance in primary hyperparathyroidism. Metabolism (1983) 0.88
Differential effects of warfarin on mRNA levels of developmentally regulated vitamin K dependent proteins, osteocalcin, and matrix GLA protein in vitro. J Cell Physiol (1994) 0.86
Effects of leptin to cultured growth plate chondrocytes. Horm Res (2003) 0.85
Structural characterization and chromosomal localization of the mouse cDNA and gene encoding the bone tyrosine phosphatase, mOST-PTP. Gene (2000) 0.83
Bone: from a reservoir of minerals to a regulator of energy metabolism. Kidney Int Suppl (2011) 0.83
Amylin inhibits bone resorption by a direct effect on the motility of rat osteoclasts. Exp Physiol (1993) 0.82
Effect of exogenous intermittent recombinant human PTH 1-34 administration and chronic endogenous parathyroid hormone excess on glucose homeostasis and insulin sensitivity. Horm Metab Res (2008) 0.82
Amylin stimulates osteoblast proliferation and increases mineralized bone volume in adult mice. Biochem Biophys Res Commun (1995) 0.82
Changes in plasma phosphate levels influence insulin sensitivity under euglycemic conditions. J Clin Endocrinol Metab (1996) 0.82
Structural evidence of a fourth Gla residue in fish osteocalcin: biological implications. Biochemistry (2005) 0.81
Reflex sympathetic dystrophy of the lower extremity: a complication of herpes zoster with dramatic response to propranolol. West J Med (1981) 0.81
Bone mineral density directly correlates with elevated serum leptin in haemodialysis patients. Nephrol Dial Transplant (2003) 0.81
Amylin in the periphery II: An updated mini-review. ScientificWorldJournal (2006) 0.80
Biologic modification of ligamentum flavum cells by marker gene transfer and recombinant human bone morphogenetic protein-2. Spine (Phila Pa 1976) (2004) 0.80
Amylin and adrenomedullin: novel regulators of bone growth. Curr Pharm Des (2002) 0.80
Hormonal regulation of acid phosphatase release by osteoclasts disaggregated from neonatal rat bone. J Cell Physiol (1987) 0.80
The role of amylin and related peptides in osteoporosis. Clin Chim Acta (2006) 0.79
Amylin fasting plasma levels are decreased in patients with osteoporosis. Osteoporos Int (2003) 0.78
Acute and chronic effect of teriparatide on glucose metabolism in women with established osteoporosis. Exp Clin Endocrinol Diabetes (2007) 0.76
[Calcium homeostasis and diabetes mellitus]. Clin Calcium (2006) 0.76
Human aging is associated with parallel reductions in insulin and amylin release. Am J Physiol (1998) 0.76
Extraction of DNA from microdissected archival tissues. Methods Mol Med (2001) 0.75
The RAD-HOME project: a pilot study of home delivery of radiology services. Arch Intern Med (2011) 1.12
Bone mass and metabolism in thalassemic children and adolescents treated with different iron-chelating drugs. J Bone Miner Metab (2004) 0.90
Interactions between the immune system and bone. World J Orthop (2011) 0.83
Role of iron metabolism and oxidative damage in postmenopausal bone loss. Bone (2008) 0.82
Malnutrition in an elderly demented population living at home. Arch Gerontol Geriatr (2011) 0.81
The use of raloxifene in osteoporosis treatment. Expert Opin Pharmacother (2013) 0.80
Impact of a phone follow-up program on persistence with teriparatide or PTH(1-84) treatment. Calcif Tissue Int (2012) 0.78
Functional decline two weeks before hospitalization in an elderly population. Aging Clin Exp Res (2010) 0.77
Ability of ultrasound bone profile score (UBPS) to discriminate between fractured and not fractured osteoporotic women. Ultrasound Med Biol (2002) 0.77
The role of circulating bone cell precursors in fracture healing. Calcif Tissue Int (2010) 0.77
Prevalence of postmenopausal osteoporosis in Italy and validation of decision rules for referring women for bone densitometry. Calcif Tissue Int (2013) 0.76
Hypovitaminosis D and organ damage in patients with arterial hypertension: a multicenter double blind randomised controlled trial of cholecalciferol supplementation (HYPODD) : study design, clinical procedures and treatment protocol. High Blood Press Cardiovasc Prev (2015) 0.76
X-ray, CT and DXA study of bone loss on medieval remains from North-West Italy. Radiol Med (2015) 0.75
Short-term urine deoxypyridinoline biological variability in the first 5 years after menopause. Clin Chem (2005) 0.75
Stress in professional care-givers working with patients with dementia: a hypothesis-generating study. Aging Clin Exp Res (2010) 0.75
Microdamage accumulation changes according to animal mass: an intraspecies investigation. Calcif Tissue Int (2011) 0.75